PMed Holdings, LLC

PASADENA, TX · Founded 2010 · CIK 0001488250 · Biotech

Hydroxyl Dendrimer Therapeutics (HDTs), a nanomedicine platform targeting inflammatory cells

pmed.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.6M
1 Form D · Apr 2010
198 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,650,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1790Azafaros——
1791Faknostics, LLC——
1792Green Growth Brands Inc.—$17M
1793PMed Holdings, LLC—$1.6M
1794Mekanistic Therapeutics, LLC——
1795SCIBAC INC.——
1796NATSAR PHARMACEUTICALS, INC.—$4.2M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Abiel Garcia, M.D.Director
  • Steve Haddad, M.D.Director
  • Charley Hartley, D.P.M.Director
  • Donald Metz, D.O.Director
  • Jorge Rodriguez, M.D.Director
  • Eric Rothenberg, M.D.Director

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.